Alkermes holder plans $373K stock sale in 2026

Alkermes plc has a beneficial owner planning to sell 7,576 shares of common stock through Merrill Lynch on NASDAQ.

Rhea-AI Filing Summary

Alkermes plc has a beneficial owner planning to sell 7,576 shares of common stock through Merrill Lynch on NASDAQ. The proposed sale has an aggregate market value of $372,936.86 and is scheduled on or after August 17, 2026.

The seller previously acquired Alkermes common stock through vesting of restricted stock unit awards, including 2,473 shares on February 23, 2025, 3,952 shares on February 22, 2025, and 1,151 shares on February 18, 2025 under the issuer’s equity compensation plan.

Key Figures

Shares to be sold: 7,576 shares Aggregate market value: $372,936.86 Proposed sale date: 08/17/2026 +3 more

6 metrics

Shares to be sold 7,576 shares Planned sale of Alkermes plc common stock through Merrill Lynch on NASDAQ

Aggregate market value $372,936.86 Market value of 7,576 Alkermes plc shares planned for sale

Proposed sale date 08/17/2026 Scheduled date for planned sale of Alkermes plc common stock

RSU vesting shares 2,473 shares Vesting of restricted stock units on 02/23/2025 under equity compensation plan

RSU vesting shares 3,952 shares Vesting of restricted stock units on 02/22/2025 under equity compensation plan

RSU vesting shares 1,151 shares Vesting of restricted stock units on 02/18/2025 under equity compensation plan

Key Terms

Form 144, restricted stock unit, equity compensation plan

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock unit financial

"Vesting of restricted stock unit awards"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being reported for Alkermes plc (ALKS) in this Form 144?

The filing reports a planned sale of 7,576 shares of Alkermes plc common stock. The shares are to be sold through Merrill Lynch on NASDAQ, with an aggregate market value of $372,936.86 as disclosed.

When is the planned sale of Alkermes plc (ALKS) shares expected to occur?

The planned sale is scheduled on or after August 17, 2026. This date is listed as the proposed sale date for the 7,576 shares of Alkermes plc common stock to be sold on NASDAQ.

What is the disclosed market value of Alkermes plc (ALKS) shares to be sold?

The planned sale covers Alkermes plc common stock with an aggregate market value of $372,936.86. This value corresponds to the 7,576 shares that the reporting holder intends to sell through Merrill Lynch.

How were the Alkermes plc (ALKS) shares acquired that are now being registered for sale?

The shares were acquired through vesting of restricted stock unit awards. Vesting events disclosed include 2,473 shares on February 23, 2025, 3,952 shares on February 22, 2025, and 1,151 shares on February 18, 2025 under Alkermes’ equity compensation plan.

Which broker and market will handle the planned sale of Alkermes plc (ALKS) shares?

The planned sale will be handled by Merrill Lynch at its New York office. The 7,576 shares of Alkermes plc common stock are expected to be sold on the NASDAQ market as disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:50 PM Accepted by SEC EDGAR 08/17/2026 - 04:50 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813312
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alkermes plc.
SEC File Number	001-35299
Address of Issuer	CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 00000
Phone	00-353-1-772-8000
Name of Person for Whose Account the Securities are To Be Sold	Nichols Christian Todd
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	7576	372936.86	166649934	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/23/2025	Vesting of restricted stock unit awards	Alkermes plc.			2473	02/23/2025	Granted as part of issuer equity compensation plan
Common Stock	02/22/2025	Vesting of restricted stock unit awards	Alkermes plc.			3952	02/22/2025	Granted as part of issuer equity compensation plan
Common Stock	02/18/2025	Vesting of restricted stock unit awards	Alkermes plc.			1151	02/18/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Christian Nichols
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)